BLLXF - Sire Bioscience Inc.

Other OTC - Other OTC Delayed Price. Currency in USD

Sire Bioscience Inc.

213 Sterling Road
Suite 206
Toronto, ON M6R 2B2
Canada
416 262 0871
http://www.sirebioscience.com

Sector(s)Healthcare
IndustryDrug Manufacturers—Specialty & Generic
Full Time Employees

Key Executives

NameTitlePayExercisedYear Born
Mr. Jeffrey ZaniniStrategic AdvisorN/AN/A1969
Mr. Brian PollaCEO, COO, Founder & DirectorN/AN/AN/A
Mr. Domenic CrudoCFO & Corp. Sec.N/AN/A1965
Mr. Adrian BurkeDirector of Marketing & DirectorN/AN/AN/A
Amounts are as of and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Sire Bioscience Inc. invests in, cultivates, produces, and sells various hemp and cannabis products in Canada. It offers cannabidiol (CBD) based wellness products, oils, and edibles, as well as animal and pet related CBD products under the yumz, MEDIflower, BIONIC, PURPLEK, INFUSIONS, CANNA BANANA, cancan, FUR BABY, CBDTECH, and LEAFBELIEF. The company is headquartered in Toronto, Canada.

Corporate Governance

Sire Bioscience Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.